FDA's Vaccine Panel to Weigh XFG Variant for New COVID Shots

(MedPage Today) -- The FDA's vaccine advisors will meet Thursday to vote on whether an XFG monovalent vaccine should be preferred for COVID-19 shots for the 2026-2027 season. The Vaccines and Related Biological Products Advisory Committee (VRBPAC...
Source
MedPage Today
Opens original article in a new tab



